Role of group B streptococcal capsular polysaccharides in the induction of septic arthritis

Journal of Medical Microbiology

Volumn 47, Issue 8, 1998, Pages 717-723

  Tissi, Luciana ^a   Von Hunolstein, Christina ^b   Bistoni, F ^a   Marangi, M ^a   Parisi, Laura ^b   Orefici, Graziella ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

POLYSACCHARIDE;

ANIMAL MODEL; ARTICLE; BACTERIAL ARTHRITIS; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; FEMALE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS AGALACTIAE;

EID: 0031856510     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-47-8-717     Document Type: Article

References (40)

1. Baker CJ, Edwards MS. Group B streptococcal infections. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus & newborn infant, 4th edn. Philadelphia, WB Saunders. 1995: 980-1054.
2. Baker CJ. Early onset group B streptococcal disease. J Pediatr 1978; 93: 124-125.
3. Gerards LJ, Cats BP, Hoogkamp-Korstanje JAA. Early neonatal group B streptococcal disease: degree of colonisation as an important determinant. J Infect 1985; 11: 119-124.
4. Weisman LE, Stoll BJ, Cruess DF et al. Early-onset group B streptococcal sepsis: a current assessment. J Pediatr 1992; 121: 428-433.
5. Anthony BF, Okada DM, Hobel CJ. Epidemiology of the group B Streptococcus: maternal and nosocomial sources for infant acquisitions J Pediatr 1979; 95: 431-436.
6. Gardner SE, Mason EO, Yow MD. Community acquisition of group B Streptococcus by infants of colonized mothers. Pediatrics 1980; 66: 873-875.
7. Geslin P, Sissia G, Jélinková J, Fremaux A, Motlová J. Serotype distribution of group B streptococci from human source in France over a 10 year period (1980-1989). Zentralbl Bakteriol Mikrobiol Hyg Abst 1992; 22 Suppl 1: 484-485.
8. Dan M. Neonatal septic arthritis. Isr J Med Sci 1983; 19: 967-971.
9. Lai TK, Hingston J, Scheifele D. Streptococcal neonatal osteomyelitis. Am J Dis Child 1980; 134: 711.
10. Memon IA, Jacobs NM, Yeh TF, Lilien LD. Group B streptococcal osteomyelitis and septic arthritis. Its occurrence in infants less than 2 months old. Am J Dis Child 1979; 133: 921-923.
11. Schwartz B, Schuchat A, Oxtoby MJ, Cochi SL, Hightower A, Broome CV. Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA 1991; 266: 1112-1114.
12. Farley MM, Harvey RC, Stull T et al. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med 1993; 328: 1807-1811.
13. Jennings HJ, Katznellenbogen E, Lugowski C, Michon F, Roy R, Kasper DL. Structure, conformation and immunology of sialic acid-containing polysaccharides of human pathogenic bacteria. Pure Appl Chem 1984; 56: 893-905.
14. Kasper DL. Bacterial capsule - old dogmas and new tricks. J Infect Dis 1986; 153: 407-415.
15. Kogan G, Brisson JR, Kasper DL, von Hunolstein C, Orefici G, Jennings HJ. Structural elucidation of the novel type VII group B Streptococcus capsular polysaccharide by high resolution NMR spectroscopy. Carbohydr Res 1995; 277: 1-9.
16. von Hunolstein C, D'Ascenzi S, Wagner B et al. Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci). Infect Immun 1993; 61: 1272-1280.
17. Wessels MR, Benedí V-J, Jennings HJ, Michon F, DiFabio JL, Kasper DL. Isolation and characterization of type IV group B Streptococcus capsular polysaccharide. Infect Immun 1989; 57: 1089-1094.
18. Wessels MR, Di Fabio JL, Benedí VJ et al. Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide. J Biol Chem 1991; 266: 6714-6719.
19. Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976; 294: 753-756.
20. Wilkinson HW. Detection of group B streptococcal antibodies in human sera by radioimmunoassay: concentrations of type-specific antibodies in sera of adults and infants infected with group B streptococci. J Clin Microbiol 1978; 7: 194-201.
21. Edwards MS, Kasper DL, Jennings HJ, Baker CJ, Nicholson-Weller A. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol 1982; 128: 1278-1283.
22. Martin TR, Ruzinski JT, Rubens CE, Chi EY, Wilson CB. The effect of type-specific polysaccharide capsule on the clearance of group B streptococci from the lungs of infants and adult rats. J Infect Dis 1992; 165: 306-314.
23. Wessels MR, Rubens CE, Benedí V-J, Kasper DL. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc Natl Acad Sci USA 1989; 86: 8983-8987.
24. Small CB, Slater LN, Lowy FD, Small RD, Salvati EA, Casey JI. Group B streptococcal arthritis in adults. Am J Med 1984; 76: 367-375.
25. Jackson LA, Hilsdon R, Farley MM et al. Risk factors for group B streptococcal disease in adults. Ann Intern Med 1995; 123: 415-420.
26. Tissi L, Marconi P, Mosci P et al. Experimental model of type IV Streptococcus agalactiae (group B Streptococcus) infection in mice with early development of septic arthritis. Infect Immun 1990; 58: 3093-3100.
27. Klegerman ME, Boyer KM, Papemiak CK, Levine L, Gotoff SP. Type-specific capsular antigen is associated with virulence in late-onset group B streptococcal type III disease. Infect Immun 1984; 44: 124-129.
28. Martin TR, Rubens CE, Wilson CB. Lung antibacterial defense mechanisms in infant and adult rats: implications for the pathogenesis of group B streptococcal infections in the neonatal lung. J Infect Dis 1988; 157: 91-100.
29. Rubens CE, Heggen LM. Tn916ΔE: a Tn916 derivative expressing erythromycin resistance. Plasmid 1988; 20: 137-142.
30. Rubens CE, Kuypers JM, Heggen LM, Wessels MR, Kasper DL. Molecular analysis of the group B streptococcal capsule genes. In: Dunny GM, Cleary PP, McKay LL (eds) Genetic and molecular biology of streptococci, lactococci and enterococci. Washington, American Society for Microbiology, 1991: 179-183.
31. Wessels MR, Haft RF, Heggen LM, Rubens CE. Identification of a genetic locus essential for capsule sialylation in type III group B streptococci. Infect Immun 1992; 60: 392-400.
32. von Hunolstein C, Nicolini L, D'Ascenzi S, Volpe C, Alfarone G, Orefici G. Sialic acid and biomass production by Streptococcus agalactiae under different growth conditions. Appl Microbiol Biotechnol 1993; 38: 458-462.
33. Warren L. The thiobarbituric acid assay of sialic acids. J Biol Chem 1959; 234: 1971-1975.
34. Reed LJ, Muench H. A single method of estimating fifty per cent endpoints. Am J Hyg 1938; 27: 493-497.
35. Molinari A, von Hunolstein C, Donnelli G, Paradisi S, Arancia G, Orefici G. Effect of some capsular components on pathogenicity of type IV and provisional type V group B streptococci. FEMS Microbiol Lett 1987; 41: 69-72.
36. Shigeoka AO, Rote NS, Santos JI, Hill HR. Assessment of the virulence factors of group B streptococci: correlation with sialic acid content. J Infect Dis 1983; 147: 857-863.
37. Rubens CE, Wessels MR, Heggen LM, Kasper DL. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci USA 1987; 84: 7208-7212.
38. Wibawan IWT, Lämmler C. Influence of capsular neuraminic acid on properties of streptococci of serological group B. J Gen Microbiol 1991; 137: 2721-2725.
39. Lerner PI, Gopalakrishna KV, Wolinsky E, McHenry MC, Tan JS, Rosenthal M. Group B Streptococcus (S. agalactiae) bacteremia in adults: analysis of 32 cases and review of the literature. Medicine (Baltimore) 1977; 56: 457-473.
40. Harrison LH, Ali A, Dwyer DM et al. Relapsing invasive group B streptococcal infection. Ann Intern Med 1995; 123: 421-427.